Works matching IS 11782595 AND DT 2024 AND VI 38 AND IP 3

Results: 8

Survey of Data Package and Sample Size of Comparative Clinical Studies for Biosimilar Developments from PMDA Assessments.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 225, doi. 10.1007/s40290-024-00525-y

By:

Kuribayashi, Ryosuke;
Hariu, Aya;
Nakano, Ayuki;
Kishioka, Yasuhiro

Publication type:

Article

Trends in Adverse Event Reporting Before and After the Introduction of the Med Safety App in Nigeria.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 251, doi. 10.1007/s40290-024-00524-z

By:

Elemuwa, Uchenna Geraldine;
Bitrus, Fraden;
Oreagba, Ibrahim Adekunle;
Osakwe, Adeline Ijeoma;
Abiodun, Abiola Sadikat;
Onu, Kenneth;
Abubakar, Asmau;
Faniyi, Angela E.;
Etuk, Victoria;
Yuah, Daniel;
Momodu, Rametu;
Adeyeye, Christiana Mojisola

Publication type:

Article

Conducting Drug Treatment Trials in Children: Opportunities and Challenges.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 179, doi. 10.1007/s40290-024-00523-0

By:

Erceg, Damir;
Jakirović, Marina;
Prgomet, Luka;
Madunić, Marina;
Turkalj, Mirjana

Publication type:

Article

Redefining the Role of Medical Affairs Professionals as Innovators and Leaders in Industry-Led Medical Education.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 167, doi. 10.1007/s40290-024-00522-1

By:

Setia, Sajita;
Loo, Elliot;
Shinde, Salil Prakash;
Singh, Manmohan;
Wong, Chew Hooi;
Thakkar, Karan

Publication type:

Article

A Sponsor's Perspective on the Contribution of Regulatory-Required Observational Post-Marketing Studies to Understanding Human Drug Product Benefit/Risk in Japan.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 217, doi. 10.1007/s40290-024-00521-2

By:

Wolter, Kevin D.;
Kamatani, Asayuki;
Suzuki, Yumiko;
Imaeda, Takayuki;
Dagher, Ramzi;
Safferman, Allan;
Junor, Rod

Publication type:

Article

Maximizing the Value of Real-World Data and Real-World Evidence to Accelerate Healthcare Transformation in China: Summary of External Advisory Committee Meetings.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 157, doi. 10.1007/s40290-024-00520-3

By:

Sun, Feng;
Bedenkov, Alexander;
Liu, Bi-Cheng;
Yang, Jiefu;
Xu, Jin-fu;
Ji, Linong;
Zhou, Min;
Zhang, Shaosen;
Li, Xinli;
Song, Yuanlin;
Chen, Pingyan;
Moreno, Carmen

Publication type:

Article

Authorized or Off-Label Use? A Structured Analysis of Summaries of Product Characteristics with Regard to Authorization in Pediatrics.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 205, doi. 10.1007/s40290-024-00519-w

By:

Herzig, Markus;
Eisenhofer, Simone;
Ruschkowski, Meike;
Neubert, Antje;
Bertsche, Astrid;
Bertsche, Thilo;
Neininger, Martina Patrizia

Publication type:

Article

Survey on the Situation of Medical Departments in the Pharmaceutical Industry in Spain.

Published in:

Pharmaceutical Medicine, 2024, v. 38, n. 3, p. 241, doi. 10.1007/s40290-024-00517-y

By:

Sanchez-Magro, Isabel;
Gomez-Lus, Susana;
Martínez-González, Javier;
Muñoz-Robles, Jorge Andrés;
Riesgo, Yolanda;
Perez, Beatriz;
Hagen, Carlos;
Viguera, Pablo

Publication type:

Article